Varun R. Kshettry

Varun R. Kshettry

Auto-generated profile, based on publicly available information

Varun R. Kshettry

Department of Neurosurgery, Cleveland Clinic Foundation, Cleveland, Ohio, United States

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2015 in Neuro-Oncology
Verified
Journal Article
Open access
PDF file
VKVarun R. Kshettry
Varun R. Kshettry
QOQuinn T. Ostrom
Quinn T. Ostrom
CKCarol Kruchko
Carol Kruchko
OAOssama Al-Mefty
Ossama Al-Mefty
GBGene H. Barnett
Gene H. Barnett
JIll S Barnholt-SloanJIll S Barnholt-Sloan
JIll S Barnholt-Sloan
Background Because World Health Organization (WHO) grades II and III meningiomas are relatively uncommon, there is limited literature on the descriptive epidemiology of these tumors, and the existing literature predates the 2000 WHO classification revisions. Our purpose was to provide a modern, population-based study of the descriptive epidemiology of WHO II and III meningiomas in the United States. Methods The Central Brain Tumor Registry of the United States (CBTRUS) was queried for intracranial meningiomas categorized by WHO grade for the 2004­–2010 study period. Age-adjusted incidence (95% confidence interval in parentheses) per 100 000 population was calculated by age, sex, race, and ethnicity. Annual percent change (APC) was calculated using Joinpoint. Results From 2004 to 2010, the incidence of WHO II intracranial meningiomas increased from 0.28 (95% CI, 0.27­–0.29) to 0.30 (95% CI, 0.28–0.32), representing an APC of 3.6% (95%CI, 0.8%–6.5%). Conversely, from 2000–2010, the incidence of WHO III meningiomas decreased from 0.13 (95% CI, 0.11–0.14) to 0.06 (95%CI, 0.06–0.07), representing an APC of −5.4% (95% CI, −6.8% to −4.0%). From 2004 to 2010, the overall proportion of WHO I, II, and III intracranial meningiomas was 94.6%, 4.2%, and 1.2%, respectively. For WHO II/III meningiomas, females in the 35–64 year age group had a higher incidence than males in the same age group, whereas males in the ≥75 year age group ≥ had a higher incidence. Black and Asian Pacific Islander races were both associated with the highest incidence of WHO II/III meningiomas. Hispanic ethnicity was not associated with any difference in incidence. Conclusion This study presents the most comprehensive evaluation of the modern descriptive epidemiology of WHO II and III meningiomas. Temporal trends likely reflect the 2000 WHO histological criteria revisions.

28 January 2021 in Pituitary
Verified
Journal Article
Closed access
PDF file
AMArbaz A. Momin
Arbaz A. Momin
MRMiguel A. Recinos
Miguel A. Recinos
GCGino Cioffi
Gino Cioffi
NPNirav Patil
Nirav Patil
PSPranay Soni
Pranay Soni
VKVarun R. Kshettry
Varun R. Kshettry

1 November 2014 in World Neurosurgery
Verified
Journal Article
Closed access
VKVarun R. Kshettry
Varun R. Kshettry
JMJeffrey P. Mullin
Jeffrey P. Mullin
RSRichard Schlenk
Richard Schlenk
PRPablo F. Recinos
Pablo F. Recinos
EBEdward C. Benzel
Edward C. Benzel

1 February 2014 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
VKVarun R. Kshettry
Varun R. Kshettry
BRBenjamin P. Rosenbaum
Benjamin P. Rosenbaum
ASAndreea Seicean
Andreea Seicean
MKMichael L. Kelly
Michael L. Kelly
NSNicholas K Schiltz
Nicholas K Schiltz
RWRobert J. Weil
Robert J. Weil

28 April 2020 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
PDParamita Das
Paramita Das
PSPranay Soni
Pranay Soni
JJJaes Jones
Jaes Jones
GHGhaith Habboub
Ghaith Habboub
JBJill S. Barnholtz-Sloan
Jill S. Barnholtz-Sloan
VKVarun R. Kshettry
Varun R. Kshettry

1 May 2020 in Journal of Neurosurgery: Spine
Verified
Journal Article
Closed access
PDF file
STShahed Tish
Shahed Tish
GHGhaith Habboub
Ghaith Habboub
MLMin Lang
Min Lang
QOQuinn T. Ostrom
Quinn T. Ostrom
CKCarol Kruchko
Carol Kruchko
VKVarun R. Kshettry
Varun R. Kshettry
OBJECTIVE: Spinal schwannoma remains the third most common intradural spinal tumor following spinal meningioma and ependymoma. The available literature is generally limited to single-institution reports rather than epidemiological investigations. As of 1/1/2004, registration of all benign central nervous system tumors in the United States became mandatory after the Benign Brain Tumor Cancer Registries Amendment Act took action, which provided massive resources for United States population-based epidemiological studies. This article describes the epidemiology of spinal schwannoma in the United States from January 1, 2006, through December 31, 2014.METHODS: In this study, the authors utilized the Central Brain Tumor Registry of the United States, which corresponds to 100% of the American population. The Centers for Disease Control and Prevention’s National Program of Cancer Registries and the National Cancer Institute’s Surveillance Epidemiology and End Results program provide the resource for this data registry. The authors included diagnosis years 2006 to 2014. They used the codes per the International Coding of Diseases for Oncology, 3rd Edition: histology code 9560/0 and site codes C72.0 (spinal cord), C70.1 (spinal meninges), and C72.1 (cauda equina). Rates are per 100,000 persons and are age-adjusted to the 2000 United States standard population. The age-adjusted incidence rates and 95% confidence intervals are calculated by age, sex, race, and ethnicity.RESULTS: There were 6989 spinal schwannoma cases between the years 2006 and 2014. The yearly incidence eminently increased between 2010 and 2014. Total incidence rate was 0.24 (95% CI 0.23–0.24) per 100,000 persons. The peak adjusted incidence rate was seen in patients who ranged in age from 65 to 74 years. Spinal schwannomas were less common in females than they were in males (incidence rate ratio = 0.85; p < 0.001), and they were less common in blacks than they were in whites (IRR = 0.52; p < 0.001) and American Indians/Alaska Natives (IRR = 0.50; p < 0.001) compared to whites. There was no statistically significant difference in incidence rate between whites and Asian or Pacific Islanders (IRR = 0.92; p = 0.16).CONCLUSIONS: The authors’ study results demonstrated a steady increase in the incidence of spinal schwannomas between 2010 and 2014. Male sex and the age range 65–74 years were associated with higher incidence rates of spinal schwannomas, whereas black and American Indian/Alaska Native races were associated with lower incidence rates. The present study represents the most thorough assessment of spinal schwannoma epidemiology in the American population.